Devices and Methods for Stimulating Nerves

Abstract

A device positioned in the vagina includes a sensor. The sensor data is used to determine whether a condition is met or exists to trigger a therapeutic response by the device. A device for stimulating nerves adjacent the vagina includes a nerve stimulating element coupled to a main body. The nerve stimulating element is positioned and designed to stimulate the vesical, Frankenhauser's and/or inferior hypogastric plexuses. The device may reside in the vaginal fornices. An implant is also provided which has a nerve stimulating element in contact with a uterosacral ligament. The device positioned in the vagina may be used to charge a power source for an implant, which may be a capacitor.

What is claimed is: 
     
         1 . A method of stimulating nerves adjacent a vaginal canal, comprising the steps of:
 positioning a device in the vagina, the device including a main body and a first nerve stimulating element coupled to the main body;   stimulating nerves adjacent the vaginal canal using the first nerve stimulating element.   
     
     
         2 . The method of  claim 1 , wherein:
 the stimulating step is carried out by stimulating nerves with the first nerve stimulating element sufficiently to change a signal transmitted by the nerves to associated nerves.   
     
     
         3 . The method of  claim 1 , wherein;
 the stimulating step is carried out with the nerves being a first target nerve plexus selected from the group of nerve plexuses consisting of the vesical plexus, the inferior hypogastric plexus and the Frankenhauser's plexuses.   
     
     
         4 . The method of  claim 1 , wherein:
 the positioning step is carried out with the device having a second nerve stimulating element; and   the stimulating step is carried out with the second nerve stimulating element stimulating a second target plexus selected from the group of nerve plexuses consisting of the vesical plexus, the inferior hypogastric plexus and the Frankenhauser's plexuses, the second target plexus being different from the first target nerve plexus.   
     
     
         5 . The method of  claim 1 , wherein:
 the positioning step is carried out with the nerve stimulating element being positioned to stimulate an autonomic plexus without intervening somatic nerves.   
     
     
         6 . The method of  claim 1 , wherein:
 the positioning step is carried out with the device positioned in the vaginal fornices, the vaginal fornices being a space between the cervix and the vagina and bounded by a plane extending through a distal end of the cervix and perpendicular to a cervical axis, the first nerve stimulating element contacting the surface of the vaginal canal proximal to the distal end of the cervix.   
     
     
         7 . The method of  claim 1 , wherein:
 the positioning step is carried out with a plurality of nerve stimulating elements, wherein all of the nerve stimulating elements are positioned in the vaginal fornices.   
     
     
         8 . The method of  claim 1 , wherein:
 the positioning step is carried out with the main body having a central opening, the cervix being positioned in the central opening and the main body extending around at least 180 degrees of the cervix relative to a cervical axis.   
     
     
         9 . The method of  claim 1 , wherein:
 the positioning step is carried out with the main body extending at least 270 degrees around the cervix.   
     
     
         10 . The method of  claim 1 , wherein:
 the positioning step is carried out with the main body extending completely around the cervix.   
     
     
         11 . The method of  claim 1 , wherein:
 the positioning step is carried out with a second nerve stimulating element, wherein the first and second nerve stimulating elements having proximal surface, wherein the proximal surface of the first and second nerve stimulating elements are longitudinally spaced relative to a cervical axis of the body by no more than 1 cm.   
     
     
         12 . The method of  claim 1 , wherein:
 the positioning step is carried out with at least eight nerve stimulating elements, wherein each nerve stimulating element has a proximal surface, wherein the proximal surface of all eight nerve stimulating elements are longitudinally spaced relative to a central axis of the body by no more than 1 cm.   
     
     
         13 . The method of  claim 1 , wherein:
 the stimulating step is carried out to treat at least one condition from the conditions consisting of urge, frequency, nocturia, urge incontinence, stress incontinence, loss of urine without sensory awareness, bladder pain, urethral pain, urethral syndrome, urinary hesitancy, pelvic floor dyssynergia, interstitial cystitis, dysuria, overactive bladder, urinary retention, hesitancy, protracted urinary stream, dysmenorrhea, pelvic pain, pelvic venous congestion syndrome, endometriosis, irritable bowel syndrome, constipation, fecal urgency, fecal incontinence, rectal pain, pain with defecation, and anal pain.   
     
     
         14 . A system for stimulating nerves adjacent a vaginal canal, the system comprising:
 a main body having an exterior surface; and   a first nerve stimulating element coupled to the main body and positioned on the exterior surface of the main body to contact an exposed surface of a vaginal canal when the main body is positioned in the vaginal canal; and   a power source coupled to the main body;   a control system coupled to the power source and the first nerve stimulating element.   
     
     
         15 . The system of  claim 14 , wherein:
 the first nerve stimulating element is configured to stimulate nerves sufficiently to change a signal transmitted by the nerves to associated nerves   
     
     
         16 . The system of  claim 14 , wherein;
 the nerve stimulating element is positioned on the main body to stimulate a first target nerve plexus selected from the group of nerve plexuses consisting of the vesical plexus, the inferior hypogastric plexus and the Frankenhauser's plexuses when the main body is positioned in the vagina.   
     
     
         17 . The system of  claim 14 , wherein:
 the first nerve stimulating element is positioned on the main body so that no intervening somatic nerves are positioned between the first nerve stimulating element and a first target plexus when the main body is positioned in the vagina.   
     
     
         18 . The system of  claim 14 , further comprising:
 at least two nerve stimulating elements, wherein at least one nerve stimulating element is positioned on a left side of a midline and at least one nerve stimulating element is positioned on a right side of the midline.   
     
     
         19 . The system of  claim 14 , further comprising:
 a controller separate from the main body, the controller being positioned outside the body when the main body is positioned in the vagina.   
     
     
         20 . The system of  claim 19 , wherein:
 the controller is configured to communicate with the control system, the controller controlling a duration of stimulation and an intensity of stimulation.   
     
     
         21 . The system of  claim 14 , wherein:
 the main body is sized and shaped to be positioned in the vaginal fornices, the vaginal fornices being a space between the cervix and the vagina and bounded by a plane extending through a distal end of the cervix and perpendicular to a cervical axis, the first nerve stimulating element contacting the surface of the vaginal canal proximal to the distal end of the cervix.   
     
     
         22 . The system of  claim 14 , further comprising:
 a plurality of nerve stimulating elements, wherein all of the nerve stimulating elements are positioned in the vaginal fornices.   
     
     
         23 . The system of  claim 14 , wherein:
 the main body is sized and shaped to be positioned entirely within the vaginal fornices.   
     
     
         24 . The system of  claim 14 , wherein:
 the main body has a central opening in which the cervix is positioned, the main body extending around at least 180 degrees of the cervix relative to a cervical axis when the main body is positioned in the vagina.   
     
     
         25 . The system of  claim 14 , wherein:
 the main body extends at least 270 degrees around the cervix.   
     
     
         26 . The system of  claim 14 , wherein:
 the control system is configured to actuate the first nerve stimulating element to treat a condition from the conditions consisting of urge, frequency, nocturia, urge incontinence, stress incontinence, loss of urine without sensory awareness, bladder pain, urethral pain, urethral syndrome, urinary hesitancy, pelvic floor dyssynergia, interstitial cystitis, dysuria, overactive bladder, urinary retention, hesitancy, protracted urinary stream, dysmenorrhea, pelvic pain, pelvic venous congestion syndrome, endometriosis, irritable bowel syndrome, constipation, fecal urgency, fecal incontinence, rectal pain, pain with defecation, and anal pain.   
     
     
         27 . The system of  claim 14 , wherein:
 the control system includes means for orienting the device about the cervix using the nerve stimulating elements.   
     
     
         28 . The system of  claim 27 , wherein:
 the orienting means includes at least one of the nerve stimulating elements emitting energy and at least one other of the nerve stimulating elements measuring the energy emitted.   
     
     
         29 . The system of  claim 27 , wherein:
 the orienting means is coupled to the control system, the control system recognizing a pattern in a parameter using the nerve stimulating elements, the pattern being used to orient the device about the cervix   
     
     
         30 . The method of  claim 1 , further comprising the step of:
 orienting the device about the cervix using the nerve stimulating elements.   
     
     
         31 . The method of  claim 1 , wherein:
 the positioning step is carried out with the device including a second nerve stimulating element coupled to the main body;   the stimulating step being carried out with the first nerve stimulating element stimulating nerves adjacent the vagina, and the second nerve stimulating element is positioned to stimulate nerves on an opposing side of the cervix from the first nerve stimulating element when viewed along a cervical axis.   
     
     
         32 . The system of  claim 14 , wherein:
 the main body includes a recess;   the first nerve stimulating element being positioned in the recess in the main body.   
     
     
         33 . The system of  claim 32 , wherein:
 the main body includes at least four recesses; and   at least four nerve stimulating elements each positioned in one of the recesses.   
     
     
         34 . The system of  claim 32 , further comprising:
 a plurality of nerve stimulating elements; and   the main body having a non-conductive wall extending outwardly relative to the recess, the non-conductive wall positioned between adjacent nerve stimulating elements.   
     
     
         35 . The system of  claim 32 , wherein:
 the main body includes a reservoir, the reservoir being fluidly coupled to the recess.   
     
     
         36 . The system of  claim 14 , further comprising:
 a first implant having a first body, a first implant nerve stimulating element coupled to the first body, and a first control system coupled to the first body, the first implant configured to be secured adjacent a uterosacral ligament so that the first implant nerve stimulating element is in contact with the uterosacral ligament.   
     
     
         37 . The system of  claim 36 , wherein:
 the first body has a first throughhole sized to receive the uterosacral ligament.   
     
     
         38 . The system of  claim 37 , wherein:
 the first body is movable from an open position to a locked position, the first body having a slot leading to the first throughhole when the first body is in the open position through which the uterosacral ligament is introduced, the locked position preventing the uterosacral ligament from moving out of the throughhole.   
     
     
         39 . The system of  claim 38 , wherein:
 the slot is reduced in size when the first body moves from the open position to the locked position thereby securing the first body to the uterosacral ligament.   
     
     
         40 . The system of  claim 38 , wherein:
 the first implant nerve stimulating element is positioned within the first throughhole so that the first implant nerve stimulating element is in contact with the uterosacral ligament.   
     
     
         41 . The system of  claim 36 , wherein:
 the first implant includes a first power source coupled to the first body, the first control system being coupled to the first power source and the first implant nerve stimulating element.   
     
     
         42 . The system of  claim 36 , wherein:
 the first implant nerve stimulating element is configured to stimulate nerves sufficiently to change a signal transmitted by the nerves to associated nerves and nerve endings.   
     
     
         43 . The system of  claim 36 , further comprising:
 a second implant nerve stimulating element coupled to the first body, the second implant nerve stimulating element positioned to apply nerve stimulus at a different position along the uterosacral ligament than the first nerve stimulating element when the first body is secured adjacent to the uterosacral ligament.   
     
     
         44 . The system of  claim 36 , wherein:
 the control system communicates with the first control system of the first implant.   
     
     
         45 . The system of  claim 36 , wherein:
 the control system and the first control system communicate to coordinate simultaneous stimulation using the first nerve stimulating element and the first implant nerve stimulating element.   
     
     
         46 . The system of  claim 36 , wherein:
 the control system and the first control system communicate to coordinate independent stimulation using the first nerve stimulating element and the first implant nerve stimulating element.   
     
     
         47 . The system of  claim 36 , wherein:
 the first implant includes a second implant nerve stimulating element.   the first body has a tubular shape with an outer surface, the second nerve stimulating element being positioned along the outer surface of the first body so that the second nerve stimulating element is in contact with the peritoneum.   
     
     
         48 . The system of  claim 14 , further comprising:
 a second nerve stimulating element coupled to the main body; and   a third nerve stimulating element coupled to the main body;   the first nerve stimulating element, the second nerve stimulating element and the third nerve stimulating element being positioned to stimulate at least three nerve plexuses selected from the group of plexuses consisting of SHP, IHP, L vesicle, R vesicle, L Frankenhauser's, and R Frankenhauser's.   
     
     
         49 . The system of  claim 48 , wherein:
 the first nerve stimulating element, the second nerve stimulating element and the third nerve stimulating element coordinate stimulation to alter sympathetic tone.   
     
     
         50 . The system of  claim 36 , wherein:
 the first implant includes a third implant nerve stimulating element coupled to the first body and positioned within the first throughhole so that the third implant nerve stimulating element contacts the uterosacral ligament when the uterosacral ligament is positioned in the first throughhole.   
     
     
         51 . The system of  claim 50 , further comprising:
 a fourth implant nerve stimulating element coupled to the first body and positioned along the outer surface of the first body and spaced apart from the second implant nerve stimulating element.   
     
     
         52 . The system of  claim 36 , further comprising;
 a second implant having a second body with an outer surface, the second implant having a fifth implant nerve stimulating element coupled to the second body.   
     
     
         53 . The system of  claim 51 , wherein:
 the second implant includes a second power source coupled to the second body and a second control system coupled to the fifth implant nerve stimulating element.   
     
     
         54 . The system of  claim 51 , wherein:
 the second body of the second implant has a second throughhole, the second body being movable from an open position to a locked position, the second body having a slot leading to the second throughhole so that the uterosacral ligament may enter the throughhole when the second body is in the open position.   
     
     
         55 . The system of  claim 54 , wherein:
 the slot is reduced in size when the second body moves from the open position to the locked position thereby preventing the uterosacral ligament from moving out of the second throughhole.   
     
     
         56 . The system of  claim 54 , wherein:
 the fifth implant nerve stimulating element of the second implant is positioned within the second throughhole so that the fifth implant nerve stimulating element is in contact with the uterosacral ligament when the second body is secured adjacent to the uterosacral ligament.   
     
     
         57 . The system of  claim 51 , further comprising:
 a sixth implant nerve stimulating element coupled to the second body of the second implant, the second body having a generally tubular shape with an outer surface, the sixth implant nerve stimulating element being positioned along the outer surface of the second body.   
     
     
         58 . The system of  claim 53 , further comprising:
 a seventh implant nerve stimulating element coupled to the second body and positioned within the second throughhole so that the seventh implant nerve stimulating element contacts the uterosacral ligament when the uterosacral ligament is positioned in the second throughhole.   
     
     
         59 . The system of  claim 51 , further comprising:
 an eighth implant nerve stimulating element coupled to the second body of the second implant and positioned along the outer surface of the second body spaced apart from the sixth implant nerve stimulating element.   
     
     
         60 . The system of  claim 51 , wherein:
 the first implant and the second implant are sized to be positioned adjacent one another on the same uterosacral ligament.   
     
     
         61 . The system of  claim 59 , further comprising;
 a third implant having a nerve stimulating element configured to be secured to the other uterosacral ligament opposite the uterosacral ligament that the first nerve stimulating element is in contact with.   
     
     
         62 . The system of  claim 60 , further comprising:
 a fourth implant having a nerve stimulating element;   the third and fourth implants are configured to be secured adjacent the same uterosacral ligament different from the uterosacral ligament that the first nerve stimulating element is in contact with.   
     
     
         63 . The system of  claim 51 , wherein:
 the first implant is configured to be positioned and secured adjacent one uterosacral ligament; and   the second implant is configured to be positioned and secured adjacent the other uterosacral ligament.   
     
     
         64 . The system of  claim 63 , wherein:
 at least one of the first control system of the first implant and the second control system of the second implant communicates with the other control system to coordinate stimulation using the first and second implants.   
     
     
         65 . The system of  claim 64 , wherein:
 the first and second control systems communicate using the first implant nerve stimulating element and the second implant nerve stimulating element.   
     
     
         66 . The system of  claim 64 , wherein:
 at least one of the first and second control systems communicates with the other control system to coordinate simultaneous application of nerve stimulus by the first implant nerve stimulating element and the second implant nerve stimulating element.   
     
     
         67 . The system of  claim 64 , wherein:
 the first and second control systems communicate to coordinate independent stimulation using the first implant nerve stimulating element and the second implant nerve stimulating element.   
     
     
         68 . The system of  claim 51 , further comprising:
 a controller separate from the main body, the controller being positioned outside the patient's body when the main body is positioned in the vagina,   the controller being configured to communicate with the control system coupled to the main body.   
     
     
         69 . The system of  claim 68 , wherein:
 the controller is configured to communicate with the control system to control a duration of stimulation and an intensity of stimulation for the first nerve stimulating element.   
     
     
         70 . The system of  claim 68 , wherein:
 the controller is configured to communicate stimulation instructions for the first control system of the first implant to the control system coupled to the main body;   the control system coupled to the main body being configured to communicate the stimulation instructions to the first control system of the first implant.   
     
     
         71 . The system of  claim 69 , wherein:
 the controller is configured to communicate instructions directly to the first control system of the first implant.   
     
     
         72 . The system of  claim 36 , further comprising:
 a second nerve stimulating element coupled to the main body;   the first nerve stimulating element, the second nerve stimulating element and the first implant nerve stimulating element being positioned to stimulate at least three nerve plexuses selected from the group of plexuses consisting of SHP, IHP, L vesicle, R vesicle, L Frankenhauser's, and R Frankenhauser's.   
     
     
         73 . The system of  claim 72 , wherein:
 the first nerve stimulating element, the second nerve stimulating element and the first implant nerve stimulating element coordinate stimulation to alter sympathetic tone.   
     
     
         74 . The system of  claim 36 , wherein:
 the first implant nerve stimulating element is positioned to stimulate the IHP.   
     
     
         75 . The system of  claim 74 , wherein:
 the first nerve stimulating element is positioned to stimulate a side of the Frankenhauser's plexus.   
     
     
         76 . The system of  claim 74 , further comprising:
 a second nerve stimulating element coupled to the main body, the second nerve stimulating element being positioned to stimulate the Frankenhauser's plexus on a side opposite from the first nerve stimulating element relative to a midline.   
     
     
         77 . The system of  claim 74 , wherein:
 the first nerve stimulating element is positioned to stimulate a side of the vesicle plexus.   
     
     
         78 . The system of  claim 74 , further comprising:
 a second nerve stimulating element coupled to the first body and positioned to stimulate a side of the vesicle plexus opposite the first nerve stimulating element relative to a midline.   
     
     
         79 . The system of  claim 51 , wherein:
 the first implant nerve stimulating element is positioned to stimulate the SHP.   
     
     
         80 . The system of  claim 79 , wherein:
 the first nerve stimulating element is positioned to stimulate a side of the Frankenhauser's plexus.   
     
     
         81 . The system of  claim 79 , further comprising:
 a second nerve stimulating element coupled to the first body and positioned to stimulate a side of the Frankenhauser's plexus opposite the first nerve stimulating element relative to a midline.   
     
     
         82 . The system of  claim 79 , wherein:
 the first nerve stimulating element is positioned to stimulate a side of the vesicle plexus.   
     
     
         83 . The system of  claim 82 , further comprising:
 a second nerve stimulating element positioned to stimulate a side of the vesicle plexus opposite the first nerve stimulating element relative to a midline.   
     
     
         84 . The method of  claim 1 , further comprising the step of:
 providing a first implant having a first body, a first implant nerve stimulating element coupled to the body, and a first implant control system coupled to the first body.   
     
     
         85 . The method of  claim 84 , further comprising the step of stimulating nerves with the first implant nerve stimulating element. 
     
     
         86 . The method of  claim 85 , further comprising the step of:
 securing the first implant adjacent to a uterosacral ligament so that the first implant nerve stimulating element is in contact with the uterosacral ligament.   
     
     
         87 . The method of  claim 84 , wherein:
 the providing step is carried out with the first body having a throughhole sized to receive the uterosacral ligament.   
     
     
         88 . The method of  claim 87 , wherein:
 the providing step is carried out with the first body being movable from an open position to a locked position, the body having a slot leading to the throughhole when the body is in the open position through which the uterosacral ligament is introduced, the locked position preventing the uterosacral ligament from moving out of the throughhole.   
     
     
         89 . The method of  claim 88 , wherein:
 the providing step is carried out with the first body having a slot which is reduced in size when the body moves from the open position to the locked position thereby securing the first body to the uterosacral ligament.   
     
     
         90 . The method of  claim 87 , wherein:
 the providing step is carried out with the first implant nerve stimulating element positioned within the throughhole so that the first implant nerve stimulating element is in contact with the uterosacral ligament.   
     
     
         91 . The method of  claim 84 , wherein:
 the providing step is carried out with the first implant including a first implant power source coupled to the first body, the first control system being coupled to the first implant power source and the first implant nerve stimulating element.   
     
     
         92 . The method of  claim 84 , wherein:
 the stimulating step is carried out with the first implant stimulating nerves sufficiently to change a signal transmitted by the nerves to associated nerves and nerve endings.   
     
     
         93 . The method of  claim 84 , wherein:
 the providing step is carried out with the first implant having a second implant nerve stimulating element coupled to the first body, the second implant nerve stimulating element positioned to apply nerve stimulus at a different position along the uterosacral ligament from the first nerve stimulating element when the first body is secured adjacent to the uterosacral ligament.   
     
     
         94 . The method of  claim 84 , wherein:
 the providing step is carried out with the control system coupled to the first nerve stimulating element configured to communicate with the control system coupled to the first implant nerve stimulating element to coordinate nerve stimulation using the first nerve stimulating element and the first implant nerve stimulating element.   
     
     
         95 . The method of  claim 94 , wherein:
 the providing step is carried out with the control system configured to communicate with the first control system of the first implant using the first nerve stimulating element and the first implant nerve stimulating element.   
     
     
         96 . The method of  claim 94 , wherein:
 the providing step is carried out with the control system and the first control system configured to communicate to coordinate simultaneous stimulation using the first nerve stimulating element and the first implant nerve stimulating element.   
     
     
         97 . The method of  claim 94 , wherein:
 the providing step is carried out with the control system and the first control system configured to communicate to coordinate independent stimulation using the first nerve stimulating element and the first implant nerve stimulating element.   
     
     
         98 . The method of  claim 84 , wherein:
 the providing step is carried out with the first implant including a second implant nerve stimulating element.   
     
     
         99 . The method of  claim 98 , wherein:
 the providing step is carried out with the first body having an outer surface, the second nerve stimulating element being positioned along the outer surface of the first body so that the second nerve stimulating element is in contact with the peritoneum.   
     
     
         100 . The method of  claim 98 , wherein:
 the providing step is carried out with the first implant including a third implant nerve stimulating element coupled to the first body and positioned within the first throughhole so that the third implant nerve stimulating element contacts the uterosacral ligament when the uterosacral ligament is positioned in the first throughhole.   
     
     
         101 . The method of  claim 98 , wherein:
 the providing step is carried out with the first implant having a fourth implant nerve stimulating element coupled to the first body and positioned along the outer surface of the first body and spaced apart from the second implant nerve stimulating element.   
     
     
         102 . The method of  claim 84 , wherein;
 the providing step is carried out with a second implant having a second body with an exterior surface, the second implant having a fifth implant nerve stimulating element coupled to the second body.   
     
     
         103 . The method of  claim 102 , further comprising:
 securing the second implant to the patient so that the fifth nerve stimulating element is in contact with a uterosacral ligament.   
     
     
         104 . The method of  claim 102 , wherein;
 the securing step is carried out with the first and second implants positioned adjacent the same uterosacral ligament.   
     
     
         105 . The method of  claim 102 , wherein:
 the securing step is carried out with the first implant secured to the patient adjacent one uterosacral ligament and the second implant being secured to the patient adjacent the other uterosacral ligament.   
     
     
         106 . The method of  claim 102 , wherein:
 the providing step is carried out with the second implant including a second control system coupled to the fifth implant nerve stimulating element.   
     
     
         107 . The method of  claim 102 , wherein:
 the providing step is carried out with the second body of the second implant having a second throughhole, the second body being movable from an open position to a locked position, the second body having a second slot leading to the second throughhole when the second body is in the open position.   
     
     
         108 . The method of  claim 107 , wherein:
 the providing step is carried out with the second slot reducing in size when the second body moves from the open position to the locked position thereby preventing the uterosacral ligament from moving out of the second throughhole.   
     
     
         109 . The method of  claim 107 , wherein:
 the providing step is carried out with the fifth implant nerve stimulating element of the second implant positioned within the second throughhole so that the fifth implant nerve stimulating element is in contact with the uterosacral ligament when the second body is secured to the uterosacral ligament.   
     
     
         110 . The method of  claim 107 , wherein:
 the providing step is carried out with the second implant having a sixth implant nerve stimulating element coupled to the second body, the second body having a generally tubular shape with an outer surface, the sixth implant nerve stimulating element being positioned along the outer surface of the second body.   
     
     
         111 . The method of  claim 107 , wherein:
 the providing step is carried out with the second implant having a seventh implant nerve stimulating element coupled to the second body and positioned within the second throughhole so that the seventh implant nerve stimulating element contacts the uterosacral ligament when the uterosacral ligament is positioned in the second throughhole.   
     
     
         112 . The method of  claim 84 , wherein:
 the securing step is carried out with the implant positioned on an anterior side of the uterosacral ligament;   the positioning step is carried out with the first nerve stimulating element positioned adjacent the vesicle plexus;   the stimulating step being carried out with the first nerve stimulating element stimulating the vesicle plexus simultaneous with the first implant nerve stimulating element to treat urinary urgency.   
     
     
         113 . The method of  claim 102 , wherein:
 the providing step is carried out with the first implant and the second implant sized to be positioned adjacent the same uterosacral ligament; and   the securing step is carried out by securing the first and second implants adjacent to the same uterosacral ligament.   
     
     
         114 . The method of  claim 106 , wherein:
 the providing step is carried out with a third implant having a nerve stimulating element configured to be secured adjacent a uterosacral ligament opposite the uterosacral ligament that the first nerve stimulating element is secured adjacent.   
     
     
         115 . The method of  claim 114 , wherein:
 the providing step is carried out with a fourth implant having a nerve stimulating element sized to be secured adjacent the same uterosacral ligament as the third nerve stimulating element   
     
     
         116 . The method of  claim 115 , further comprising the step of:
 securing the third implant and the fourth implant adjacent to the same uterosacral ligament which is different from the uterosacral ligament that the first implant is secured to.   
     
     
         117 . The method of  claim 1 , further comprising the step of:
 providing a second nerve stimulating element and a third nerve stimulating element both coupled to the main body;   the positioning step is carried out so that the first nerve stimulating element, the second nerve stimulating element and the third nerve stimulating element are positioned to stimulate at least three nerve plexuses selected from the group of plexuses consisting of SHP, IHP, L vesicle, R vesicle, L Frankenhauser's, and R Frankenhauser's; and   the stimulating step being carried out with the first nerve stimulating element, the second nerve stimulating element and the third nerve stimulating element coordinating stimulation to alter sympathetic tone.   
     
     
         118 . The method of  claim 106 , further comprising the step of:
 communicating information between the first control system of the first implant and the second control system of the second implant.   
     
     
         119 . The method of  claim 118 , wherein:
 the communicating step is carried out with the first and second control systems communicating using at least one nerve stimulating element coupled to the first body and at least one nerve stimulating element coupled to the second body.   
     
     
         120 . The method of  claim 106 , wherein:
 the communicating step is carried out so that at least one of the first and second control systems communicates with the other control system to coordinate simultaneous stimulation with the first implant nerve stimulating element and the fifth implant nerve stimulating element.   
     
     
         121 . The method of  claim 106 , wherein:
 the communicating step is carried out with the first and second control systems communicating to coordinate independent stimulation using the first nerve stimulating element and the fifth nerve stimulating element.   
     
     
         122 . The method of  claim 106 , wherein;
 the communicating step is carried out with a controller separate from the main body, the controller being positioned outside the patient's body when the main body is positioned in the vagina, the controller being configured to communicate control information to the control system.   
     
     
         123 . The method of  claim 122 , wherein:
 the communicating step is carried out with the controller communicating with the control system to control a duration of stimulation and an intensity of stimulation.   
     
     
         124 . The method of  claim 122 , wherein:
 the communicating step is carried out with the controller configured to communicate stimulation instructions for the first implant to the control system coupled to the main body, the control system receiving the stimulation instructions for the first implant from the controller and subsequently communicating the stimulation instructions to the first control system of the first implant.   
     
     
         125 . The method of  claim 122 , wherein:
 the communicating step is carried out with the controller configured to communicate stimulation instructions directly to the first control system of the first implant.   
     
     
         126 . The method of  claim 84 , wherein:
 the providing step is carried out with a second nerve stimulating element coupled to the main body;   the securing steps are carried out so that the first nerve stimulating element, the second nerve stimulating element and the first implant nerve stimulating element are positioned to stimulate at least three nerve plexuses selected from the group of plexuses consisting of SHP, IHP, L vesicle, R vesicle, L Frankenhauser's, and R Frankenhauser's.   
     
     
         127 . The method of  claim 126 , wherein:
 the stimulating step is carried out with the first nerve stimulating element, the second nerve stimulating element and the first implant nerve stimulating element coordinating stimulation to alter sympathetic tone.   
     
     
         128 . The method of  claim 126 , wherein:
 the securing step is carried out with the first implant nerve stimulating element positioned to stimulate the IHP.   
     
     
         129 . The method of  claim 128 , wherein:
 the securing step is carried out so that the first nerve stimulating element is positioned to stimulate a side of the Frankenhauser's plexus.   
     
     
         130 . The method of  claim 129 , wherein:
 the securing step is carried out so that the second nerve stimulating element is positioned to stimulate the Frankenhauser's plexus on a side opposite the first nerve stimulating element relative to a midline.   
     
     
         131 . The method of  claim 128 , wherein:
 the securing step is carried out so that the first nerve stimulating element is positioned to stimulate a side of the vesicle plexus.   
     
     
         132 . The method of  claim 131 , wherein:
 the securing step is carried out with the second nerve stimulating element positioned to stimulate a side of the vesicle plexus opposite the first nerve stimulating element relative to a midline.   
     
     
         133 . The method of  claim 126 , wherein:
 the securing step is carried out so that the first implant nerve stimulating element is positioned to stimulate the SHP.   
     
     
         134 . The method of  claim 133 , wherein:
 the securing step is carried out so that the first nerve stimulating element is positioned to stimulate a side of the Frankenhauser's plexus.   
     
     
         135 . The method of  claim 134 , wherein:
 the securing step is carried out so that the second nerve stimulating element is positioned to stimulate a side of the Frankenhauser's plexus opposite the first nerve stimulating element relative to a midline.   
     
     
         136 . The method of  claim 133 , wherein:
 the securing step is carried out so that the first nerve stimulating element is positioned to stimulate a side of the vesicle plexus.   
     
     
         137 . The method of  claim 136 , wherein:
 the securing step is carried out so that the second nerve stimulating element is positioned to stimulate a side of the vesicle plexus opposite the first nerve stimulating element relative to a midline.   
     
     
         138 . A method of nerve stimulation, comprising the steps of:
 providing a first implant having a first body and a first nerve stimulating element coupled to the first body, the first nerve stimulating element being configured to stimulate nerves;   forming an access opening in the patient leading to the peritoneum;   creating an opening in the peritoneum to expose a uterosacral ligament;   securing the first implant to the patient so that the first nerve stimulating element is in contact with the uterosacral ligament; and   stimulating nerves using the first nerve stimulating element.   
     
     
         139 . The method of  claim 138 , wherein:
 the securing step is carried out with the first implant secured directly to the uterosacral ligament beneath the peritoneum.   
     
     
         140 . The method of  claim 138 , further comprising the step of:
 sizing the uterosacral ligament before the securing step; and   selecting the first implant after the sizing step based upon a size of the uterosacral ligament.   
     
     
         141 . The method of  claim 138 , wherein:
 the providing step is carried out with the first implant also having a first power source coupled to the first body and a first control system, the first control system being coupled to the first power source and the first nerve stimulating element.   
     
     
         142 . The method of  claim 138 , wherein:
 the stimulating step is carried out with the first nerve stimulating element configured to stimulate nerves sufficient to change a signal transmitted by the nerves to associated nerves and nerve endings.   
     
     
         143 . The method of  claim 138 , wherein:
 the providing step is carried out with the first implant having a second nerve stimulating element coupled to the first body;   the securing step being carried out so that the second nerve stimulating element is positioned at a different position along the uterosacral ligament from the first nerve stimulating element.   
     
     
         144 . The method of  claim 138 , wherein:
 the providing step is carried out with the first body having a first throughhole sized to receive the uterosacral ligament.   
     
     
         145 . The method of  claim 144 , wherein:
 the providing step is carried out with the first body being movable from an open position to a locked position, the first body having a slot leading to the first throughhole when the first body is in the open position;   the securing step being carried out by introducing the uterosacral ligament into the throughhole though the slot and moving the body to the locked position.   
     
     
         146 . The method of  claim 145 , wherein:
 the securing step is carried out with the slot being reduced in size when the first body moves to the locked position thereby securing the first body to the uterosacral ligament.   
     
     
         147 . The method of  claim 144 , wherein:
 the providing step is carried out with the first nerve stimulating element positioned within the first throughhole so that the first nerve stimulating element is in contact with the uterosacral ligament when the first body is secured to the uterosacral ligament.   
     
     
         148 . The method of  claim 138 , wherein:
 the providing step is carried out with the first implant having a second nerve stimulating element, the first body having an outer surface, the second nerve stimulating element being positioned along the outer surface of the first body;   the securing step being carried out so that the second nerve stimulating element is in contact with the peritoneum.   
     
     
         149 . The method of  claim 138 , wherein:
 the providing step is carried out with the first implant having a third nerve stimulating element coupled to the first body and positioned within the first throughhole so that the third nerve stimulating element contacts the uterosacral ligament when the uterosacral ligament is positioned in the first throughhole.   
     
     
         150 . The method of  claim 148 , wherein:
 the providing step is carried out with the first implant having a fourth nerve stimulating element coupled to the first body and positioned along the outer surface of the first body spaced apart from the second nerve stimulating element.   
     
     
         151 . The method of  claim 138 , wherein:
 the providing step is carried out with a second implant having a second body with an outer surface, the second implant also having a fifth nerve stimulating element coupled to the second body.   
     
     
         152 . The method of  claim 151 , further comprising the step of:
 securing the second implant to the patient so that the fifth nerve stimulating element is in contact with a uterosacral ligament;   the providing step being carried out with the second implant having a second control system.   
     
     
         153 . The method of  claim 152 , wherein:
 the providing step is carried out with the second implant having a second power source coupled to the second body;   the second control system being coupled to the second power source and the fifth nerve stimulating element.   
     
     
         154 . The method of  claim 151 , wherein:
 the securing step is carried out with the second implant secured to the patient so that the fifth nerve stimulating element is in contact with the same uterosacral ligament as the first nerve stimulating element.   
     
     
         155 . The method of  claim 151 , wherein:
 the securing step is carried out with the second implant being secured to the patient so that the fifth nerve stimulating element is in contact with a different uterosacral ligament than the first implant is secured to.   
     
     
         156 . The method of  claim 151 , wherein:
 the providing step is carried out with the second body of the second implant having a second throughhole sized to receive the uterosacral ligament.   
     
     
         157 . The method of  claim 156 , wherein:
 the providing step is carried out with the second body being movable from an open position to a locked position, the second body having a second slot leading to the second throughhole, the second body being in the open position to introducing the uterosacral ligament into the second throughhole;   the securing step being carried out by moving the uterosacral ligament into the second throughhole through the slot and moving the second body to the locked position.   
     
     
         158 . The method of  claim 157 , wherein:
 the securing step being carried out with the second slot being reduced in size when the second body moves to the locked position.   
     
     
         159 . The method of  claim 157 , wherein:
 the providing step is carried out with the fifth nerve stimulating element positioned within the second throughhole so that the fifth nerve stimulating element is in contact with the uterosacral ligament after the securing step.   
     
     
         160 . The method of  claim 151 , wherein:
 the providing step is carried out with the second implant having a sixth nerve stimulating element coupled to the second body, the sixth nerve stimulating element being positioned along the outer surface of the second body;   the securing step is carried out so that the sixth nerve stimulating element is in contact with the peritoneum.   
     
     
         161 . The method of  claim 156 , wherein:
 the providing step is carried out with the second implant having a seventh nerve stimulating element coupled to the second body and positioned within the second throughhole;   the securing step being carried out so that the seventh nerve stimulating element contacts the uterosacral ligament at a spaced apart location from the fifth nerve stimulating element when the uterosacral ligament is positioned in the second throughhole.   
     
     
         162 . The method of  claim 161 , wherein:
 the providing step is carried out with the fifth nerve stimulating element and the seventh nerve stimulating element being positioned at opposite ends of the second throughhole.   
     
     
         163 . The method of  claim 138 , further comprising the steps of:
 sizing the uterosacral ligament; and   selecting the implant based on the sizing step.   
     
     
         164 . The method of  claim 163 , wherein:
 the sizing step is carried out by taking a first measurement and a second measurement of the ligament at spaced apart locations; and   the providing step is carried out with the implant having a tapered throughhole;   the selecting step is carried out with the first and second measurements being used to select the implant so that the tapered throughhole is appropriately sized relative to the uterosacral ligament.   
     
     
         165 . The method of  claim 152 , further comprising the step of:
 communicating information from the first control system to the second control system.   
     
     
         166 . The method of  claim 165 , wherein:
 the communicating step is carried out with the first control system communicating with the second control system using at least one nerve stimulating element coupled to the first body.   
     
     
         167 . The method of  claim 166 , wherein:
 the communicating step is carried out with the second control system communicating with the first control system using at least one nerve stimulating element coupled to the second body.   
     
     
         168 . The method of  claim 166 , wherein:
 the communicating step is carried out with the first control system controlling generation of a radiofrequency signal which is received by the second control system.   
     
     
         169 . The method of  claim 165 , wherein:
 the communicating step is carried out with the first and second control systems coordinating simultaneous nerve stimulation with the first nerve stimulating element and the second nerve stimulating element.   
     
     
         170 . The method of  claim 165 , wherein:
 the stimulating step is carried out with the first and second nerve stimulating elements stimulating the same plexus.   
     
     
         171 . The method of  claim 165 , wherein:
 the communicating step is carried out with the first and second control systems coordinating independent nerve stimulation with the first nerve stimulating element and the second nerve stimulating element.   
     
     
         172 . The method of  claim 138 , wherein:
 the providing step is carried out with the first nerve stimulating element being an electrode.   
     
     
         173 . The method of  claim 138 , wherein:
 the stimulating step is carried out with the first nerve stimulating element stimulating the middle rectal plexus.   
     
     
         174 . The method of  claim 173 , wherein:
 the stimulating step is carried out with the first nerve stimulating element stimulating the middle rectal plexus to treat at least one condition from the list of conditions consisting of fecal urge, bowel disorder, and incontinence.   
     
     
         175 . The method of  claim 174 , wherein:
 the providing step is carried out with a second nerve stimulating element coupled to the first body, the second nerve stimulating element being secured to the patient so that the second nerve stimulating element is positioned to stimulate the IHP;   the stimulating step being carried out with the first nerve stimulating element stimulating the middle rectal plexus and the second nerve stimulating element stimulating the IHP and middle rectal plexus to treat a rectal condition.   
     
     
         176 . The method of  claim 138 , wherein:
 the stimulating step is carried out with the first nerve stimulating element stimulating a hypogastric nerve.   
     
     
         177 . A system for stimulating nerves, comprising
 a first body having an exterior surface;   a first nerve stimulating element coupled to the first body;   a first power source coupled to the first body; and   a first control system coupled to the first power source and the first nerve stimulating element.   
     
     
         178 . The system of  claim 177 , further comprising:
 a second nerve stimulating element coupled to the body, the second nerve stimulating element positioned to apply nerve stimulus at a different position along a uterosacral ligament from the first nerve stimulating element when the first body is secured to the uterosacral ligament.   
     
     
         179 . The system of  claim 177 , wherein:
 the first nerve stimulating element is configured to stimulate nerves sufficiently to change a signal transmitted by the nerves to associated nerves and nerve endings.   
     
     
         180 . The system of  claim 177 , wherein:
 the control system is configured to actuate the first nerve stimulating element at a different time from the second nerve stimulating element.   
     
     
         181 . The system of  claim 177 , wherein:
 the first body has a first throughhole sized to receive the uterosacral ligament.   
     
     
         182 . The system of  claim 181 , wherein:
 the first body is movable from an open position to a locked position, the first body having a slot leading to the first throughhole when the first body is in the open position through which the uterosacral ligament is introduced   
     
     
         183 . The system of  claim 182 , wherein:
 the slot reduces in size when the first body moves to the locked position so that the first body may be secured to the uterosacral ligament in the locked position.   
     
     
         184 . The system of  claim 182 , wherein:
 the first nerve stimulating element is positioned within the first throughhole so that the first nerve stimulating element is in contact with the uterosacral ligament.   
     
     
         185 . The system of  claim 177 , further comprising:
 a second nerve stimulating element;   the first body having an outer surface;   the second nerve stimulating element being positioned along the outer surface of the first body.   
     
     
         186 . The system of  claim 177 , further comprising:
 a third nerve stimulating element coupled to the first body and positioned within the first throughhole so that the third nerve stimulating element contacts the uterosacral ligament when the uterosacral ligament is positioned in the first throughhole.   
     
     
         187 . The system of  claim 185 , further comprising:
 a fourth nerve stimulating element coupled to the first body and positioned along the outer surface of the first body spaced apart from the second nerve stimulating element.   
     
     
         188 . The system of  claim 177 , further comprising;
 a second body having an exterior surface; and   a fifth nerve stimulating element coupled to the second body;   
     
     
         189 . The system of  claim 188 , further comprising:
 a second control system coupled to the second body and the fifth nerve stimulating element.   
     
     
         190 . The system of  claim 188 , further comprising:
 a second power source coupled to the second body.   
     
     
         191 . The system of  claim 188 , wherein:
 the second body has a second throughhole sized to receive a uterosacral ligament.   
     
     
         192 . The system of  claim 191 , wherein:
 the second body is movable from an open position to a locked position, the second body having a second slot leading to the second throughhole, the second body being in the open position for introduction of the uterosacral ligament into the second throughhole through the slot.   
     
     
         193 . The system of  claim 192 , wherein:
 the second slot reduces in size when the second body moves to the locked position to secure the second body to the uterosacral ligament.   
     
     
         194 . The system of  claim 192 , wherein:
 the fifth nerve stimulating element is positioned within the second throughhole so that the fifth nerve stimulating element is in contact with the uterosacral ligament when the second body is secured to the uterosacral ligament.   
     
     
         195 . The system of  claim 177 , further comprising:
 a sixth nerve stimulating element coupled to the second body, the sixth nerve stimulating element being positioned along the outer surface of the second body.   
     
     
         196 . The system of  claim 177 , further comprising:
 a seventh nerve stimulating element coupled to the second body and positioned within the second throughhole so that the seventh nerve stimulating element contacts the uterosacral ligament when the uterosacral ligament is positioned in the second throughhole.   
     
     
         197 . The system of  claim 195 , further comprising:
 an eighth nerve stimulating element coupled to the second body and positioned along the outer surface of the second body spaced apart from the sixth nerve stimulating element.   
     
     
         198 . The system of  claim 177 , wherein:
 the first control system is configured to communicate with the second control system.   
     
     
         199 . The system of  claim 198 , wherein:
 the first control system communicates with the second control system using at least one nerve stimulating element coupled to the first body.   
     
     
         200 . The system of  claim 199 , wherein:
 the second control system also uses at least one nerve stimulating element coupled to the second body for communicating with the first control system.   
     
     
         201 . The system of  claim 198 , wherein:
 the first and second control systems communicate to coordinate nerve stimulation by the first nerve stimulating element and the fifth nerve stimulating element.   
     
     
         202 . The system of  claim 198 , wherein:
 the first and second control systems communicate to coordinate simultaneous nerve stimulation with the first nerve stimulating element and the fifth nerve stimulating element.   
     
     
         203 . The system of  claim 198 , wherein:
 the first and second control systems communicate to coordinate independent nerve stimulation with the first nerve stimulating element and the fifth nerve stimulating element.   
     
     
         204 . The system of  claim 177 , wherein:
 the first nerve stimulating element is an electrode.   
     
     
         205 . The system of  claim 177 , wherein:
 the first nerve stimulating element is configured to stimulate the middle rectal plexus when positioned in contact with a uterosacral ligament.   
     
     
         206 . The system of  claim 205 , wherein:
 the first nerve stimulating element stimulates the middle rectal plexus to treat at least one condition from the list of conditions consisting of fecal urge, bowel disorder, and incontinence.   
     
     
         207 . The system of  claim 205 , further comprising:
 a second nerve stimulating element coupled to the first body, the second nerve stimulating element being secured to the patient so that the second nerve stimulating element is positioned to stimulate the IHP;   wherein the first and second nerve stimulating elements stimulate the IHP and middle rectal plexus to treat a rectal condition,   stimulating the IHP and the middle rectal plexus to treat rectal conditions.   
     
     
         208 . The system of  claim 177 , wherein:
 the first nerve stimulating element is configured to be positioned on the uterosacral ligament so that the first nerve stimulating element stimulates the hypogastric nerve.   
     
     
         209 . The system of  claim 177 , wherein:
 the body has a throughhole in which the uterosacral ligament is positioned, the throughhole being tapered.   
     
     
         210 . The method of  claim 1 , further comprising the step of:
 assessing a current orientation of the device;   the positioning step being carried out with the device positioned in the vaginal fornices, the device also having a control system and a plurality of nerve stimulating elements, the positioning step being carried out to position the device in a starting orientation;   the assessing step being carried out to determine the current orientation of the device; and   reassigning the plurality of nerve stimulating elements using the control system based on a change in orientation determined in the assessing step.   
     
     
         211 . The method of  claim 210 , wherein:
 the providing step is carried out with the control system automatically carrying out the assessing step.   
     
     
         212 . The method of  claim 210 , further comprising the step of:
 sensing a parameter related to the starting orientation of the device;   storing the parameter related to the starting orientation in the control system of the device; and   the assessing step being carried out with the device sensing the parameter in the current orientation; and   comparing the parameters from the starting orientation and the current orientation.   
     
     
         213 . The method of  claim 212 , wherein:
 the assessing step is carried out with the parameter being an electrophysiological parameter.   
     
     
         214 . The method of  claim 213 , wherein:
 the assessing step is carried out with the parameter being electrical activity sensed by the device.   
     
     
         215 . The method of  claim 213 , wherein:
 the assessing step is carried out with the first nerve stimulating element being used to sense the parameter.   
     
     
         216 . The method of  claim 210 , wherein:
 the providing step is carried out by providing an object, the device having a sensor configured to sense the object; and   the assessing step is carried out using the sensor to sense the object.   
     
     
         217 . The method of  claim 216 , further comprising the step of:
 placing the object at a predetermined location relative to the user's body during the assessing step;   sensing the object with the sensor when the object is in the predetermined position to assess the current orientation of the device.   
     
     
         218 . The method of  claim 216 , wherein:
 the providing step is carried out with the object forming a magnetic field and the sensor being a magnetic sensor.   
     
     
         219 . The method of  claim 216 , wherein:
 the providing step is carried out with the device having a controller that includes the object;   placing the controller at a predetermined position relative to the user; and   initiating the assessing step by using the controller to instruct the device to assess the current orientation of the device in the vagina.   
     
     
         220 . The method of  claim 210 , wherein:
 the providing step is carried out with the device including a gravity sensor;   the assessing step being initiated using the controller while the user is in a predetermined body position, the controller sending a signal to the control system of the device to carry out the assessing step when the user is in the predetermined body position;   the assessing step being carried out with the gravity sensor transmitting data to the control system relating to the current orientation of the device.   
     
     
         221 . The method of  claim 210 , wherein:
 the providing step is carried out by also providing a first implant having a first body, a first implant nerve stimulating element coupled to the body, and a first implant control system coupled to the first body, the first implant being implanted in the user.   
     
     
         222 . The method of  claim 221 , wherein:
 the assessing step being carried out with the device including a sensor that senses a parameter relating to the first implant.   
     
     
         223 . The method of  claim 221 , wherein:
 the assessing step is carried out with the device sensing electrical activity of the first implant.   
     
     
         224 . The method of  claim 222 , wherein:
 the assessing step is carried out with the control system sensing a starting parameter of the first implant when the device is in the starting orientation, the control system saving the starting parameter and comparing the starting parameter with a current parameter sensed by the sensor when the device is in the current orientation.   
     
     
         225 . The method of  claim 221 , further comprising the step of
 securing the first implant adjacent to a uterosacral ligament so that the first implant nerve stimulating element is in contact with the uterosacral ligament.   
     
     
         226 . The method of  claim 210 , wherein:
 the providing step is carried out with the device having a controller external to the user's body;   placing the controller at a predetermined body position of the user;   the assessing step is carried out with the device having a sensor configured to sense the controller during the placing step.   
     
     
         227 . The system of  claim 14 , further comprising:
 a plurality of nerve stimulating elements coupled to the main body;   the control system includes means for assessing an orientation of the device, the assessing means being configured to assess a current orientation, wherein the control system is configured to reassign the plurality of nerve stimulating elements based on the change in orientation from a starting orientation to the current orientation.   
     
     
         228 . The system of  claim 227 , wherein:
 the control system automatically assesses the current orientation of the device and automatically reassigns the plurality of nerve stimulating elements based on the change from the starting orientation to the current orientation.   
     
     
         229 . The system of  claim 227 , wherein:
 the control system includes a sensor and means for storing a parameter sensed by the sensor relating to the starting orientation of the device.   
     
     
         230 . The system of  claim 229 , wherein:
 the sensor measures an electrophysiological parameter.   
     
     
         231 . The system of  claim 229 , wherein:
 the sensor senses electrical activity in tissue.   
     
     
         232 . The system of  claim 231 , wherein:
 the sensor includes the first nerve stimulating element.   
     
     
         233 . The system of  claim 227 , further comprising:
 an object separate from the device; and   a sensor coupled to the main body and configured to remotely sense the object.   
     
     
         234 . The system of  claim 233 , wherein:
 the object is positioned at a predetermined location relative to the user when the sensor is used to sense the object.   
     
     
         235 . The system of  claim 233 , wherein:
 the object forms a magnetic field; and   the sensor is a magnetic sensor.   
     
     
         236 . The system of  claim 233 , further comprising:
 a controller which includes the object, wherein the controller is placed at a predetermined position relative to the user, wherein the controller is used by the user to send a signal to the device to instruct the sensor to sense the object and assess the current orientation.   
     
     
         237 . The system of  claim 227 , further comprising:
 a controller configured to communicate with the control system of the device;   the control system of the device including a gravity sensor;   the controller configured to send a signal to the control system to activate the gravity sensor and assess a current orientation of the device.   
     
     
         238 . The system of  claim 227 , further comprising:
 a first implant having a first body, a first implant nerve stimulating element coupled to the body, and a first implant control system coupled to the first body, the first implant being configured to be implanted in the body of the user;   the control system of the device including a sensor to sense a parameter related to the first implant.   
     
     
         239 . The system of  claim 238 , wherein:
 the sensor is configured with the parameter being related to electrical activity of the first implant.   
     
     
         240 . The system of  claim 239 , wherein:
 the control system of the device compares a current parameter sensed by the sensor with a starting parameter relating to the starting orientation.   
     
     
         241 . The system of  claim 240 , wherein:
 the control system stores the starting parameter which is sensed by the sensor when the device is in the starting orientation, the control system also configured to sense the current parameter and compare the starting parameter with the current parameter to determine the orientation of the device.   
     
     
         242 . The system of  claim 238 , wherein:
 the implant is configured to be secured to a uterosacral ligament.   
     
     
         243 . The system of  claim 210 , further comprising:
 a controller external to the body, the controller being positioning at a predetermined body position; and   the controller includes a sensor which is capable of sensing at least part of the device in the current orientation when positioned within the vaginal fornices, the controller transmitting a signal to the control system of the device relating to the current orientation, the control system reassigning the plurality of nerve stimulating elements in accordance with the change in orientation of the device from the starting orientation to the current orientation.   
     
     
         244 . The method of  claim 138 , wherein:
 the providing step is carried out with the first implant having a first power source coupled to the first body.   
     
     
         245 . The method of  claim 244 , wherein:
 the providing step is carried out with the first power source being a battery.   
     
     
         246 . The method of  claim 244 , wherein:
 the providing step is carried out with the first power source being a capacitor.   
     
     
         247 . The method of  claim 246 , wherein:
 the providing step is carried out with the capacitor including graphene and polymer.   
     
     
         248 . The method of  claim 246 , wherein:
 the providing step is carried out with the capacitor having layers of graphene and polymer.   
     
     
         249 . The method of  claim 246 , wherein:
 the providing step is carried out with the first implant including a first power source, the first power source being a capacitor and the implant not including a battery.   
     
     
         250 . The method of  claim 246 , wherein:
 the providing step is carried out with the capacitor sized to provide at least 2 days of power under peak operating conditions.   
     
     
         251 . The method of  claim 246 , wherein:
 the providing step is carried out with the capacitor sized to provide no more than 60 days of power under peak operating conditions.   
     
     
         252 . The method of  claim 84 , wherein:
 the providing step is carried out with the first implant having a first power source coupled to the first body.   
     
     
         253 . The method of  claim 252 , wherein:
 the providing step is carried out with the first power source being a battery.   
     
     
         254 . The method of  claim 252 , wherein:
 the providing step is carried out with the first power source being a capacitor.   
     
     
         255 . The method of  claim 254 , wherein:
 the providing step is carried out with the capacitor including graphene and polymer.   
     
     
         256 . The method of  claim 255 , wherein:
 the providing step is carried out with the capacitor including layers of graphene and polymer.   
     
     
         257 . The method of  claim 254 , wherein:
 the providing step is carried out with the first implant not including a battery.   
     
     
         258 . The method of  claim 254 , wherein:
 the providing step is carried out with the capacitor sized to provide at least 2 days of power under peak operating conditions.   
     
     
         259 . The method of  claim 254 , wherein:
 the providing step is carried out with the capacitor sized to provide no more than 60 days of power under peak operating conditions.   
     
     
         260 . The system of  claim 36 , further comprising:
 means for creating a magnetic field coupled to the main body;   the first implant including a first power source which stores energy, the first implant power source being coupled to the first control system of the first implant, the first implant also having an induction coil positioned within the magnetic field to induce a current therein and charge the first implant power source.   
     
     
         261 . The system of  claim 260 , wherein:
 the first implant power source is a capacitor.   
     
     
         262 . The method of  claim 284 , wherein:
 the providing step is carried out with the device having means for creating a magnetic field coupled to the main body, the first implant having an induction coil and a first implant power source coupled to the induction coil for charging the first implant power source, the induction coil positioned within the magnetic field to induce a current therein to charge the first implant power source.   
     
     
         263 . The method of  claim 262 , wherein:
 the providing step is carried out with the first implant power source being a capacitor.   
     
     
         264 . The method of  claim 138 , wherein:
 the providing step is carried out with the first implant having a first power source coupled to the first body.   
     
     
         265 . The method of  claim 263 , wherein:
 the providing step is carried out with the first power source being a capacitor.   
     
     
         266 . The method of  claim 265 , wherein:
 the providing step is carried out with the capacitor including graphene and polymer.   
     
     
         267 . The method of  claim 265 , further comprising the step of:
 placing a device in the vagina, the device having means for creating a magnetic field;   the providing step being carried out with the first implant having an induction coil positioned in the magnetic field.   
     
     
         268 . The method of  claim 263 , wherein:
 the providing step is carried out with the first implant not including a battery.   
     
     
         269 . The method of  claim 265 , wherein:
 the providing step is carried out with the capacitor sized to provide at least 2 days of power under peak operating conditions.   
     
     
         270 . The method of  claim 265 , wherein:
 the providing step is carried out with the capacitor sized to provide no more than 60 days of power for operating the first implant under peak operating conditions.   
     
     
         271 . The system of  claim 177 , wherein:
 the first implant has a first power source coupled to the implant control system.   
     
     
         272 . The system of  claim 271 , wherein:
 the first implant power source is a capacitor.   
     
     
         273 . The system of  claim 271 , wherein:
 the first implant power source is a battery.   
     
     
         274 . The system of  claim 272 , wherein:
 the capacitor includes graphene and polymer.   
     
     
         275 . The system of  claim 271 , further comprising;
 a device sized to fit in the vagina, the device having means for creating a magnetic field;   the first implant having an induction coil positioned in the magnetic field to induce a current therein for charging the first power source.   
     
     
         276 . The system of  claim 271 , wherein:
 the first implant does not include a battery.   
     
     
         277 . The system of  claim 272 , wherein:
 the capacitor is sized to provide at least 2 days of power to operate the first implant under peak operating conditions.   
     
     
         278 . The system of  claim 272 , wherein:
 the capacitor is sized to provide no more than 60 days of power for operating the first implant under peak operating conditions.   
     
     
         279 . A method of implanting a nerve stimulator to stimulate a hypogastric nerve, comprising the steps of:
 providing a first implant having a first body, a first nerve stimulating element coupled to the first body, and an implant control system coupled to the first nerve stimulating element;   forming an access opening in the patient leading to the peritoneum;   creating an opening in the peritoneum to expose a hypogastric nerve;   securing the first implant to the patient so that the first nerve stimulating element is in contact with the hypogastric nerve; and   stimulating the hypogastric nerve using the first nerve stimulating element.   
     
     
         280 . A method of charging a power source for an implanted medical device, comprising the steps of;
 providing a device having means for creating a magnetic field;   positioning the device in the vaginal with the magnetic field creating means positioned in the vaginal fornices;   activating the magnetic field creating means to create the magnetic field after the positioning step, wherein the magnetic field impinges upon an implanted medical device in the user to charge a power supply coupled to and powering the implanted medical device.   
     
     
         281 . A device for charging a power source for an implant, comprising:
 a main body;   a power source coupled to the main body; and   means for creating a magnetic field coupled to the main body; and   a control system coupled to the power source and to the magnetic field creating means.   
     
     
         282 . The device of  claim 281 , wherein:
 the main body is sized and shaped to be positioned in the vaginal fornices.   
     
     
         283 . The device of  claim 281 , wherein:
 the main body is sized and shaped to be positioned entirely within the vaginal fornices.   
     
     
         284 . The device of  claim 281 , wherein:
 the main body has a central opening in which the cervix is positioned, the main body extending around at least 180 degrees of the cervix relative to a cervical axis when the main body is positioned in the vagina.   
     
     
         285 . The device of  claim 284 , wherein:
 the main body extends completely around the cervix.   
     
     
         286 . The method of  claim 1 , wherein:
 the positioning step is carried out with a controller separate from the main body, the controller being positioned outside the main body when the main body is positioned in the vagina, the positioning step is carried out with the controller being a personal electronic device.   
     
     
         287 . The system of  claim 19 , wherein: the controller is a personal electronic device. 
     
     
         288 . The method of  claim 1 , wherein:
 the positioning step is carried out with the device having a control system and a sensor in communication with the control system.   
     
     
         289 . The method of  claim 288 , wherein:
 the positioning step is carried out with the sensor being coupled to the main body.   
     
     
         290 . The method of  claim 288 , wherein:
 the positioning step is carried out with the control system configured to determine whether a condition exists in data from the sensor;   the stimulating step being altered in response to the condition existing.   
     
     
         291 . The method of  claim 288 , wherein:
 the positioning step is carried out with the device including a controller in wireless communication with the control system, the sensor being coupled to at least one of the controller and the main body, the controller being positioned outside the vagina when the main body is positioned in the vagina.   
     
     
         292 . The method of  claim 291 , wherein:
 the positioning step is carried out with the controller configured to determine whether a condition exists in data from the sensor, the controller wirelessly communicating with the control system when the condition exists; and   the stimulating step being altered by the control system in response to the condition existing.   
     
     
         293 . The method of  claim 291 , further comprising the step of:
 transmitting information wirelessly from the controller to the control system related to data from the sensor.   
     
     
         294 . The method of  claim 288 , wherein:
 the positioning step is carried out with the sensor sensing a cardiovascular parameter.   
     
     
         295 . The method of  claim 288 , wherein:
 the positioning step is carried out with the sensor sensing a respiration.   
     
     
         296 . The method of  claim 288 , wherein:
 the positioning step is carried out with the sensor sensing a temperature.   
     
     
         297 . The method of  claim 288 , wherein:
 the positioning step is carried out with the sensor being an accelerometer.   
     
     
         298 . The method of  claim 288 , wherein:
 the positioning step is carried out with the sensor being a microphone.   
     
     
         299 . The method of  claim 288 , wherein:
 the positioning step is carried out with the sensor converting vibration to an electrical signal.   
     
     
         300 . The method of  claim 288 , wherein:
 the positioning step is carried out with the sensor including a piezoelectric element.   
     
     
         301 . The method of  claim 288 , wherein:
 the positioning step is carried out with the sensor sensing a pulse.   
     
     
         302 . The method of  claim 288 , wherein:
 the positioning step is carried out with the sensor being an optical sensor.   
     
     
         303 . The method of  claim 288 , wherein:
 the positioning step is carried out with the sensor sensing a heartbeat.   
     
     
         304 . The method of  claim 303 , further comprising the step of:
 sensing the heartbeat with the sensor.   
     
     
         305 . The method of  claim 288 , further comprising the step of:
 sensing a blood pressure with the sensor.   
     
     
         306 . The method of  claim 288 , further comprising the step of:
 determining whether a condition exists in data from the sensor; and   the stimulating step being altered in response to the condition existing from the determining step.   
     
     
         307 . The method of  claim 288 , further comprising the step of:
 sensing with the sensor to obtain data; and   determining whether a condition exists in the data.   
     
     
         308 . The method of  claim 307 , wherein:
 the stimulating step is altered in response to the condition existing from the determining step.   
     
     
         309 . The method of  claim 307 , wherein: the determining step is carried out by the control system. 
     
     
         310 . The method of  claim 307 , wherein:
 the determining step is carried out by a controller in wireless communication with a control system coupled to the main body; and   the positioning step being carried out with the controller positioned outside the vagina when the main body is positioned in the vagina.   
     
     
         311 . The method of  claim 307 , wherein:
 the determining step is carried out with the condition being an arrhythmia condition.   
     
     
         312 . The method of  claim 307 , wherein:
 the determining step is carried out with the condition being related to heart rate.   
     
     
         313 . The method of  claim 307 , wherein:
 the determining step is carried out with the condition being based at least in part upon a baseline condition.   
     
     
         314 . The method of  claim 307 , wherein:
 the determining step is carried out with the baseline condition being related to a measurement taken at a prior time.   
     
     
         315 . The method of  claim 314 , wherein:
 the determining step is carried out with the measurement being taken by the sensor at the prior time.   
     
     
         316 . The method of  claim 307 , further comprising the step of:
 sensing the heartbeat using the sensor for a period of time to obtain heartbeat data;   determining whether a heart beat variability calculated using the heart beat data meets a condition.   
     
     
         317 . The method of  claim 316 , further comprising the step of:
 altering the stimulating step based upon the heart beat variability from the determining step meeting the condition.   
     
     
         318 . The method of  claim 307 , wherein:
 the positioning step being carried out with a control system coupled to the main body, the sensor being coupled to the control system; and   the determining step is carried out with the control system.   
     
     
         319 . The method of  claim 307 , wherein:
 the positioning step is carried out with the device including a control system coupled to the main body, the device also including a controller positioned outside the vagina when the main body is positioned in the vagina, the controller being in wireless communication with the control system of the device.   
     
     
         320 . The method of  claim 319 , wherein:
 the positioning step is carried out with the controller being carried external to the vagina.   
     
     
         321 . The method of  claim 319 , wherein:
 the positioning step is carried out with the controller being worn.   
     
     
         322 . The method of  claim 319 , wherein:
 the positioning step being carried out with the controller worn on a limb.   
     
     
         323 . The method of  claim 319 , wherein:
 the positioning step being carried out with the controller worn around the waist.   
     
     
         324 . The method of  claim 1 , wherein:
 the positioning step is carried out with the device including a collection reservoir coupled to the main body.   
     
     
         325 . The method of  claim 324 , wherein:
 the positioning step is carried out with the collection reservoir configured to hold material from the vagina.   
     
     
         326 . The method of  claim 324 , further comprising the step of:
 collecting material from the vagina in the collection reservoir.   
     
     
         327 . The method of  claim 326 , wherein:
 the positioning step is carried out with a low pressure source, at a pressure less than atmospheric pressure, being in fluid communication with the collection reservoir to assist in drawing material into the collection reservoir.   
     
     
         328 . The method of  claim 327 , wherein:
 the collecting step is carried out with the material collected in the collection reservoir including a first microbe.   
     
     
         329 . The method of  claim 324 , further comprising the step of:
 assessing the material; and   the stimulating step being altered in response to the assessing step.   
     
     
         330 . The method of  claim 324 , further comprising the step of:
 assessing the material; and   selecting a therapeutic material based on the assessing step.   
     
     
         331 . The method of  claim 330 , further comprising:
 coupling the therapeutic material to the main body of the device; and   delivering the therapeutic material to the vagina by repositioning the device in the vagina with the therapeutic material coupled to the main body.   
     
     
         332 . The method of  claim 331 , wherein:
 the delivering step is carried out with the therapeutic material carried by an insert coupled to the body.   
     
     
         333 . The method of  claim 331 , wherein:
 the delivering step is carried out with the therapeutic material carried in a material reservoir.   
     
     
         334 . The method of  claim 333 , wherein:
 the positioning step is carried out with the material reservoir being removable from the main body.   
     
     
         335 . The method of  claim 333 , further comprising the step of:
 replacing the material reservoir with another material reservoir.   
     
     
         336 . The method of  claim 333 , wherein:
 the positioning step is carried out with the material reservoir being part of a material reservoir module, the material reservoir module including a sensor.   
     
     
         337 . The method of  claim 335 , wherein:
 the positioning step is carried out with the sensor of the reservoir module sensing a concentration of ions.   
     
     
         338 . The method of  claim 335 , wherein:
 the positioning step is carried out with a magnetic actuator forcing material from the material reservoir.   
     
     
         339 . The method of  claim 335 , wherein:
 the positioning step is carried out with the magnetic actuator vibrating the main body.   
     
     
         340 . The method of  claim 332 , wherein:
 the positioning step is carried out with the material reservoir including a valve that prevents fluid from entering the material reservoir.   
     
     
         341 . The method of  claim 335 , wherein:
 the positioning step is carried out with the material reservoir being removable from the main body.   
     
     
         342 . The method of  claim 1 , wherein:
 the positioning step is carried out with the main body having a first expandable portion to increase a first dimension on the main body.   
     
     
         343 . The method of  claim 342 , wherein:
 the positioning step is carried out with the main body having a central axis, the first expandable portion increasing the first dimension in a transverse direction to the central axis.   
     
     
         344 . The method of  claim 342 , wherein:
 the positioning step is carried out with the main body having a central axis, the first expandable portion increasing a peripheral length of the main body when viewed along the central axis.   
     
     
         345 . The method of  claim 342 , wherein:
 the positioning step is carried out with the main body having a central opening, the cervix being positioned in the central opening and defining a cervical axis, the first expandable portion increasing the first dimension in a transverse direction to the cervical axis.   
     
     
         346 . The method of  claim 342 , wherein:
 the positioning step is carried out with the main body having a second expandable portion which also increases the first dimension when expanded.   
     
     
         347 . The method of  claim 346 , wherein:
 the positioning step is carried out with the main body having a central opening, the cervix being positioned in the central opening and defining a cervical axis.   
     
     
         348 . The method of  claim 347 , wherein:
 the positioning step is carried out with the second expandable portion increasing a peripheral length when viewed along the cervical axis.   
     
     
         349 . The method of  claim 347 , wherein:
 the positioning step is carried out with the second expandable portion reducing the size of the central opening when expanded.   
     
     
         350 . The method of  claim 342 , wherein:
 the positioning step is carried out with the first expandable portion reducing the size of the central opening when expanded.   
     
     
         351 . A method of delivering a therapeutic material in a vaginal canal, comprising the steps of:
 positioning a device in the vagina, the device including a main body and a first sensor coupled to the main body, the device also including a material reservoir containing a therapeutic material and coupled to the main body;   sensing data with the sensor;   determining whether a condition exists from the data in the sensing step; and   delivering the therapeutic material when the condition exists from the determining step.   
     
     
         352 . The method of  claim 351 , wherein:
 the sensing step is carried out with the sensor sensing an ion concentration.   
     
     
         353 . The method of  claim 351 , wherein:
 the sensing step is carried out with the sensor being a pH sensor producing pH sensor data; and   the delivering step being carried out with an amount of the therapeutic material being selected based upon the pH sensor data.   
     
     
         354 . The method of  claim 351 , wherein:
 the delivering step is carried out with the therapeutic material including a hormone.   
     
     
         355 . The method of  claim 351 , wherein:
 the delivering step is carried out with the therapeutic material including estrogen.   
     
     
         356 . The method of  claim 351 , wherein:
 the sensing steps is carried out with the sensor being a blood pressure sensor; and   the delivering step is carried out with the therapeutic material selected to alter the blood pressure.   
     
     
         357 . The method of  claim 351 , wherein:
 the positioning and sensing steps are carried out with the sensor being a a heart beat sensor; and   the delivering step is carried out with the therapeutic material selected to alter at least one of a heart rate and a heart rhythm.   
     
     
         358 . The method of  claim 351 , wherein:
 the positioning step is carried out with the main body having a central opening, the cervix being positioned in the central opening and the main body extending at least 270 degrees around the cervix.   
     
     
         359 . A method of delivering a therapeutic material in a vaginal canal, comprising the steps of:
 positioning a device having a control system in the vagina while a sensor is positioned outside the vagina, the sensor being coupled to a controller which is in wireless communication with the control system of the device, the device including a main body, the main body also having a material reservoir coupled thereto which contains a therapeutic material;   sensing data with the sensor;   determining whether a condition exists from the data in the sensing step; and   delivering the therapeutic material when the determining step determines the condition exists.   
     
     
         360 . The method of  claim 359 , wherein:
 the positioning and sensing steps are carried out with the sensor being a a blood pressure sensor; and   the delivering step is carried out with the therapeutic material selected to alter the blood pressure.   
     
     
         361 . The method of  claim 359 , wherein:
 the positioning and sensing steps are carried out with the sensor being a a heart beat sensor; and   the delivering step is carried out with the therapeutic material selected to alter at least one of a heart rate and a heart rhythm.   
     
     
         362 . The method of  claim 359 , wherein:
 the positioning step is carried out with the main body having a central opening, the cervix being positioned in the central opening and the main body extending at least 270 degrees around the cervix.   
     
     
         363 . The system of  claim 14 , further comprising:
 a sensor in communication with the control system.   
     
     
         364 . The system of  claim 363 , wherein:
 the control system is configured to determine whether a condition exists in data from the sensor, the control system altering stimulation with the first nerve stimulating element in response to the condition existing.   
     
     
         365 . The system of  claim 363 , wherein:
 the sensor is coupled to the main body.   
     
     
         366 . The system of  claim 363 , further comprising:
 a controller in wireless communication with the control system, the sensor being coupled to at least one of the controller and to the main body, the controller being positioned outside the vagina when the main body is positioned in the vagina.   
     
     
         367 . The system of  claim 366 , wherein:
 the sensor is coupled to the controller so that the sensor is also positioned outside the vagina when the main body is positioned in the vagina.   
     
     
         368 . The system of  claim 366 , wherein:
 the controller is wirelessly coupled to the control system to transmit information related to data from the sensor.   
     
     
         369 . The system of  claim 366 , wherein:
 the controller is configured to determine whether a condition exists in data from the sensor, the controller wirelessly communicating with the control system when the condition exists; and   the control system altering stimulation with the first nerve stimulating element in response to the condition existing.   
     
     
         370 . The system of  claim 363 , wherein:
 the sensor senses a cardiovascular parameter.   
     
     
         371 . The system of  claim 363 , wherein:
 the sensor senses a respiration.   
     
     
         372 . The system of  claim 363 , wherein:
 the sensor converts vibration to an electrical signal.   
     
     
         373 . The system of  claim 363 , wherein:
 the sensor includes a piezoelectric element.   
     
     
         374 . The system of  claim 363 , wherein:
 the sensor senses a pulse.   
     
     
         375 . The system of  claim 363 , wherein:
 the sensor is an optical sensor.   
     
     
         376 . The system of  claim 363 , wherein:
 the sensor senses a heartbeat.   
     
     
         377 . The system of  claim 363 , further comprising:
 the sensor senses a heartbeat.   
     
     
         378 . The system of  claim 363 , wherein:
 the sensor being a blood pressure sensor.   
     
     
         379 . The system of  claim 363 , wherein:
 the control system is configured to receive information from the sensor, the control system also configured to determine whether a condition exists in the information from the sensor.   
     
     
         380 . The system of  claim 379 , wherein:
 the control system is configured with the condition being related to heart rate.   
     
     
         381 . The system of  claim 379 , wherein:
 the control system is configured with the condition being related to an arrhythmia.   
     
     
         382 . The system of  claim 379 , wherein:
 the control system is configured with the condition being based at least in part upon a baseline condition.   
     
     
         383 . The system of  claim 382 , wherein:
 the control system is configured with the baseline condition being related to a measurement taken at a prior time.   
     
     
         384 . The system of  claim 363 , wherein:
 the sensor senses a heart beat;   the control system is configured with the condition being related to a heartbeat variability calculation, the control system configured to calculate a heart beat variability and determine whether the heart beat variability meets the condition.   
     
     
         385 . The system of  claim 363 , further comprising:
 a controller configured to receive information from the sensor, the control system also configured to determine whether a condition exists in the information from the sensor.   
     
     
         386 . The system of  claim 385 , wherein:
 the controller is configured with the condition being related to an arrhythmia.   
     
     
         387 . The system of  claim 385 , wherein:
 the controller is configured with the condition being related to heart rate.   
     
     
         388 . The system of  claim 385 , wherein:
 the controller is configured with the condition being based at least in part upon a baseline condition.   
     
     
         389 . The system of  claim 388 , wherein:
 the controller is configured with the baseline condition being related to a measurement taken at a prior time.   
     
     
         390 . The system of  claim 385 , wherein:
 the sensor senses a heart beat;   the controller is configured with the condition being related to a heartbeat variability calculation, the control system configured to calculate a heart beat variability and determine whether the heart beat variability meets the condition.   
     
     
         391 . The system of  claim 385 , wherein:
 the controller is positioned outside the vagina when the main body is positioned in the vagina, the controller being in wireless communication with the control system of the device.   
     
     
         392 . The system of  claim 385 , wherein:
 the controller is worn outside the vagina.   
     
     
         393 . The system of  claim 385 , wherein:
 the controller is worn on a limb.   
     
     
         394 . The system of  claim 385 , wherein:
 the controller is worn on the arm.   
     
     
         395 . The system of  claim 385 , wherein:
 the controller is worn on the wrist.   
     
     
         396 . The system of  claim 385 , wherein:
 the controller is worn around the waist.   
     
     
         397 . The system of  claim 14 , further comprising:
 a collection reservoir coupled to the main body.   
     
     
         398 . The system of  claim 397 , wherein:
 the collection reservoir is configured to hold a material from the vagina.   
     
     
         399 . The system of  claim 398 , wherein:
 the collection reservoir is configured to collect and contain material from the vagina.   
     
     
         400 . The system of  claim 397 , further comprising:
 a low pressure source which is at a pressure less than atmospheric pressure, the low pressure source being in fluid communication with the collection reservoir to assist in drawing material into the collection reservoir.   
     
     
         401 . The system of  claim 398 , further comprising:
 means for assessing the material in the vagina and determining whether a condition exists, the assessing means being coupled to the control system.   
     
     
         402 . The system of  claim 401 , further comprising:
 a therapeutic material held by the main body; and   a material delivery element which delivers the therapeutic material to the vagina when the assessing means determines the condition exists.   
     
     
         403 . The system of  claim 401 , wherein:
 the assessing means includes a sensor coupled to the control system.   
     
     
         404 . The system of  claim 403 , wherein:
 the material delivery element is carried out with the therapeutic material carried by an insert coupled to the body.   
     
     
         405 . The system of  claim 402 , further comprising:
 a material reservoir coupled to the main body which contains the therapeutic material.   
     
     
         406 . The system of  claim 405 , wherein:
 the material reservoir is part of a removable material reservoir module.   
     
     
         407 . The system of  claim 405 , further comprising:
 a sensor coupled to at least one of the material reservoir and the main body.   
     
     
         408 . The system of  claim 407 , wherein:
 the sensor sensing a concentration of ions.   
     
     
         409 . The system of  claim 407 , wherein:
 the sensor sensing a pH of the material.   
     
     
         410 . The system of  claim 407 , wherein:
 the sensor sensing a conductivity of the material.   
     
     
         411 . The system of  claim 407 , wherein:
 the material reservoir module includes a valve that prevents material from entering the collection reservoir under atmospheric conditions.   
     
     
         412 . The system of  claim 404 , wherein:
 the material reservoir being removable from the main body.   
     
     
         413 . The system of  claim 14 , wherein:
 the main body has a first expandable portion to increase a first dimension on the main body.   
     
     
         414 . The system of  claim 413 , wherein:
 the main body has a central axis, the first expandable portion increasing the first dimension in a transverse direction to the central axis.   
     
     
         415 . The system of  claim 413 , wherein:
 the main body has a central axis, the first expandable portion increasing a peripheral length of the main body when viewed along the central axis and when expanded.   
     
     
         416 . The system of  claim 413 , wherein:
 the main body has a second expandable portion which also increases the first dimension.   
     
     
         417 . The system of  claim 413 , wherein:
 the positioning step is carried out with the main body having a central opening, the cervix being positioned in the central opening and defining a cervical axis.   
     
     
         418 . The system of  claim 417 , wherein:
 the first expandable portion of the main body increasing a peripheral length when viewed along the cervical axis.   
     
     
         419 . The system of  claim 417 , wherein:
 the main body has a second expandable portion , the second expandable portion reducing the size of the central opening when expanded.   
     
     
         420 . The system of  claim 413 , wherein:
 the first expandable portion of the main body expands to reduce the size of the central opening when expanded.   
     
     
         421 . A system of delivering a therapeutic material in a vaginal canal, comprising:
 a main body;   a first sensor coupled to the main body, the main body also including a material reservoir containing a therapeutic material and coupled to the main body;   a control system in communication with the first sensor, the control system determining whether a condition exists from data received from the sensor, the control system configured to release the therapeutic material from the material reservoir when the condition exists.   
     
     
         422 . The system of  claim 421 ; wherein:
 the sensor senses an ion concentration.   
     
     
         423 . The system of  claim 421 , wherein:
 the sensor is a pH sensor that produces pH sensor data; and   the control system selecting the amount of therapeutic material to deliver based on the pH sensor data to alter the pH of the vagina.   
     
     
         424 . The system of  claim 421 , wherein:
 the therapeutic material contained in the material reservoir includes estrogen.   
     
     
         425 . The system of  claim 421 , wherein:
 the sensor is a blood pressure sensor; and   the therapeutic material selected to alter the blood pressure.   
     
     
         426 . The system of  claim 421 , wherein:
 the sensor is a heart beat sensor; and   the therapeutic material being selected to alter at least one of a heart rate and a heart rhythm.   
     
     
         427 . The system of  claim 421 , wherein:
 the main body has a central opening, the cervix being positioned in the central opening and the main body extending at least 270 degrees around the cervix.   
     
     
         428 . The system of  claim 421 , wherein;
 the sensor is a pH sensor; and   the control system delivers a controlled amount of therapeutic material based upon the pH measurement by the pH sensor to alter the pH of the vagina.   
     
     
         429 . A system of delivering a therapeutic material in a vaginal canal, comprising:
 a main body;   a control system coupled to the main body;   a controller positioned outside the vagina when the main body is positioned in the vagina;   a sensor in communication with the controller, the controller being in wireless communication with the control system;   a material reservoir coupled to the main body, the material reservoir containing a therapeutic material;   the controller being configured to determining whether a condition exists from data from the sensor and communicate with the control system that the condition exists; and   the control system delivering the therapeutic material when the controller determines that the condition exists.   
     
     
         430 . The system of  claim 429 , wherein:
 the sensor is a blood pressure sensor; and   the therapeutic material being selected to alter the blood pressure.   
     
     
         431 . The system of  claim 429 , wherein:
 the sensor is a heart beat sensor; and   the therapeutic material being selected to alter at least one of a heart rate and a heart rhythm.   
     
     
         432 . The system of  claim 429 , wherein:
 the main body having a central opening, the cervix positioned in the central opening and the main body extending at least 270 degrees around the cervix when the main body is positioned in the vagina.   
     
     
         433 . The system of  claim 263 , wherein:
 the sensor is a temperature sensor.   
     
     
         434 . The system of  claim 263 , wherein:
 the sensor is an accelerometer.   
     
     
         435 . The system of  claim 263 , wherein:
 the sensor being a microphone.   
     
     
         436 . The system of  claim 402 , further comprising:
 a magnetic actuator coupled to the material reservoir, the magnetic actuator forcing material from the material reservoir.   
     
     
         437 . The system of  claim 436 , wherein:
 the magnetic actuator is coupled to the main body and configured to vibrate the main body.   
     
     
         438 . The system of  claim 402 , wherein:
 the material reservoir is removable from the main body.   
     
     
         439 . The system of  claim 438 , wherein:
 the therapeutic material includes a hormone.